XCPCNL Business Services Announces Reverse Merger with Centiment Capital Holdings
22 juil. 2022 06h30 HE
|
XCPCNL Business Services Corporation
Charlotte, North Carolina, July 22, 2022 (GLOBE NEWSWIRE) -- XCPCNL Business Services Corporation (OTC Pink: XCPL), a venture development business that leverages knowledge, skill, and experience in...
Actipulse Neuroscience Announces Successful Clinical Trial Using Fast Gamma Magnetic Stimulation for the Treatment of Alzheimer's Disease
30 sept. 2021 15h00 HE
|
Actipulse Neuroscience
BOSTON, Sept. 30, 2021 (GLOBE NEWSWIRE) -- Today, the results of a recent pilot clinical trial, funded by neurotech company Actipulse Neuroscience, have demonstrated that its non-invasive...
Cortech Solutions Named to 2011 Inc. 5000 List of Fastest-Growing Private Companies for Third Year in a Row
24 août 2011 13h25 HE
|
Cortech Solutions, Inc.
Wilmington, NC, Aug. 24, 2011 (GLOBE NEWSWIRE) -- Research laboratory system integrator Cortech Solutions has, for the third year in a row, been named to the Inc. 5000 List. Inc. magazine ranked...
Neuronetics, Inc. Raises $30 Million in Series E Financing
16 mai 2011 08h30 HE
|
Neuronetics
MALVERN, PA--(Marketwire - May 16, 2011) - Neuronetics, Inc., maker of the NeuroStar TMS (Transcranial Magnetic Stimulation) Therapy® System for the treatment of major depression*, announced today...
New Trial Data Confirm Clinical Effectiveness and Good Adherence Rates With NeuroStar TMS Therapy in Patients With Major Depressive Disorder Treated in a Real World Practice Setting
15 mai 2011 19h00 HE
|
Neuronetics
HONOLULU, HI--(Marketwire - May 15, 2011) - Results of a Neuronetics-sponsored, multisite observational study of patients with major depressive disorder (MDD) treated with Neuronetics' NeuroStar...
Neuronetics Receives TiE50 Award for Technology Entrepreneurship
09 mai 2011 08h30 HE
|
Neuronetics
MALVERN, PA--(Marketwire - May 9, 2011) - Neuronetics, Inc., maker of the NeuroStar Transcranial Magnetic Stimulation (TMS) Therapy® System, has been selected by TiE Silicon Valley as a 2011 recipient...
New Data Show No Negative Long-Term Effect in Cognitive Function in Patients With Major Depressive Disorder Treated With NeuroStar TMS Therapy(R)
14 avr. 2011 13h30 HE
|
Neuronetics
HONOLULU, HI--(Marketwire - Apr 14, 2011) - In an open-label study of patients with major depressive disorder (MDD) who had not benefitted from prior antidepressant medication and were treated with...
Neuronetics Appoints Vice President of Health Policy and Government Relations
02 mars 2011 08h00 HE
|
Neuronetics
MALVERN, PA--(Marketwire - March 2, 2011) - Neuronetics, Inc. today announced that Mary Hailey, an industry executive with more than 25 years of experience in designing and implementing healthcare...
NovaVision's FDA-Cleared Visual Restoration Therapy (VRT) System and Company Assets Now Available
19 juil. 2010 08h00 HE
|
The Magnum Group
TIBURON, CA--(Marketwire - July 19, 2010) - NovaVision, Inc., headquartered in Boca Raton, Fla., filed for Chapter 7 Bankruptcy in the State of Florida (Case #10-21343-PGH) on April 28, 2010...